BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19962855)

  • 21. Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: results from a nationwide interview survey.
    Park B; Choi KS; Lee HY; Jun JK; Park EC
    Vaccine; 2012 Aug; 30(40):5844-8. PubMed ID: 22828587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of hepatitis B vaccination in women prisoners in two prisons in England.
    Plugge EH; Yudkin PL; Douglas N
    J Public Health (Oxf); 2007 Dec; 29(4):429-33. PubMed ID: 17878212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH; Wang LY; Hu CT; Huang SC; Huang LC; Lin SS; Chiang YM; Liu TT; Chen CL
    J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B vaccination coverage among adults--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):509-11. PubMed ID: 16691181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum uric acid, hyperuricemia and body mass index in children and adolescents with intellectual disabilities.
    Lin JD; Lin PY; Lin LP; Hsu SW; Yen CF; Fang WH; Wu SR; Chien WC; Loh CH; Chu CM
    Res Dev Disabil; 2009; 30(6):1481-9. PubMed ID: 19674870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with the new German hepatitis B vaccination strategy since 1995.
    Krämer A; Prüfer-Krämer L
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():35-7. PubMed ID: 12537724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and associated risk factors of anemia in children and adolescents with intellectual disabilities.
    Lin JD; Lin PY; Lin LP; Hsu SW; Loh CH; Yen CF; Fang WH; Chien WC; Tang CC; Wu CL
    Res Dev Disabil; 2010; 31(1):25-32. PubMed ID: 19717276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
    Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
    Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.
    Lu SN; Chen CH; Chen TM; Lee PL; Wang JH; Tung HD; Hung CH; Lee CM; Changchien CS
    Vaccine; 2006 Feb; 24(6):759-65. PubMed ID: 16159687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Household survey of hepatitis B vaccine coverage among Brazilian children.
    Luna EJ; Veras MA; Flannery B; de Moraes JC;
    Vaccine; 2009 Aug; 27(39):5326-31. PubMed ID: 19616495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain).
    Salleras L; Dominguez A; Bruguera M; Cardeñosa N; Batalla J; Carmona G; Navas E; Taberner JL
    Vaccine; 2005 Mar; 23(17-18):2181-4. PubMed ID: 15755591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of inpatient care and its determinants among persons with intellectual disabilities in day care centres in Taiwan.
    Lin JD; Wu JL; Lee PN
    J Intellect Disabil Res; 2004 Oct; 48(Pt 7):655-62. PubMed ID: 15357685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [National hepatitis B vaccination closer to implementation, but not soon enough; recommendations from the Dutch Health Council].
    Galama JM
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1339-42. PubMed ID: 11484429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in caregivers of children and adolescents with intellectual disabilities: use of WHOQOL-BREF survey.
    Lin JD; Hu J; Yen CF; Hsu SW; Lin LP; Loh CH; Chen MH; Wu SR; Chu CM; Wu JL
    Res Dev Disabil; 2009; 30(6):1448-58. PubMed ID: 19660901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B vaccination coverage among Iranian children aged 15-26 months in 2006.
    Esteghamati A; Keshtkar AA; Nadjafi L; Gouya MM; Salaramoli M; Roshandel G; Yaghini F
    East Mediterr Health J; 2011 Feb; 17(2):93-100. PubMed ID: 21735942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.